Baseline Characteristic mean (SD) unless otherwise indicated | Main cohort | 6-months follow up cohort | ||||
---|---|---|---|---|---|---|
All | Improvement on GAS at discharge | No improvement on GAS at discharge | All | Improvement on GAS at 6 months | No improvement on GAS at 6 months | |
N | 469 | 381 | 63 | 121 | 99 | 19 |
Age | 81.1 (6.7) | 81.2 (6.8) | 80.7 (6.6) | 80.8 (6.7) | 80.9 (6.7) | 79.8 (7.0) |
Sex [female n (%)] | 311 (66.3%) | 251 (65.9%) | 40 (63.5%) | 84 (69.4%) | 70 (70.7%) | 12 (63.2%) |
Program length (days) | 58.1 (19.0) | 59 (17.6) | 54.1 (25.2) | 60.8 (23.8) | 61.5 (25.8) | 55.5 (10.8) |
MMSE | 25.6 (3.8) | 25.7 (3.7) | 25.4 (3.8) | 26.1 (3.3) | 26.1 (3.4) | 25.5 (2.5) |
BBS | 37.3 (9.7) | 37.7 (9.3) | 36.1 (10.9) | 38.2 (9.5) | 37.8 (9.8) | 39.3 (7.9) |
POMA | 9.6 (3.3) | 9.7 (3.3) | 9.3 (3.6) | 9.9 (3.6) | 9.7 (3.3) | 10.1 (3.3) |
EMS | 16.1 (2.9) | 16.2 (2.8) | 15.9 (3.3) | 16.5 (2.8) | 16.4 (2.9) | 16.5 (2.6) |
Lawton Brody | 3.7 (2.1) | 3.5 (2.0) | 4.0 (2.4) | 3.0 (1.9) | 3.0 (1.9) | 3.0 (1.7) |
TUG | 22.8 (11.9) | 22.4 (10.5) | 24.7 (18.5) | 22.2 (10.5) | 22.5 (10.5) | 21.4 (10.9) |
Frailty Index | 0.30 (0.11) | 0.29 (0.11) | 0.31 (0.12) | 0.26 (0.10) | 0.26 (0.10) | 0.27 (0.11) |
GAS, number of goals | 1.64 (0.81) | 1.67 (0.83) | 1.44 (0.76)* | 1.52 (0.76) | 1.55 (0.80) | 1.37 (0.60) |